The Japanese Ministry of Health, Labour and Welfare (MHLW) has cleared Roche's Avastin (bevacizumab) as a combination therapy and monotherapy to treat the aggressive form of brain cancer glioblastoma. The first new medicine that is ...
Tags: Glioblastoma Therapy, Medicine
Genmab and ADC Therapeutics have partnered to co-develop a new antibody-drug conjugate (ADC) product conjugate to treat multiple cancer indications. The collaboration will integrate Genmab's high-affinity fully human antibody targeting ...
Tags: Genmab, ADC Partner
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine
Chengdu Huasun Group Inc., Ltd. (SZSE: 000790) announced yesterday that its biological tech subsidiary has been supported by China in doing an anticancer research. The research is concerned with the utilization of Iodine [131I] Metuximab ...
Tags: Health, Medicine, Anticancer Product
LED Medical Diagnostics, a developer of tissue fluorescence visualization technologies, has announced that its patented VELscope Vx oral examination device is presently involved in a Phase III study, which is sponsored by the University of ...
Tags: Oral Cancer Study, Medicine
Verisante Technology, a provider of cancer detection technology, has entered into an exclusive agreement with Frontière Médicale EUROPE to distribute Verisante Aura in the UK and Ireland. Verisante Aura is meant for the ...
Saladax Biomedical, US-based developer of diagnostic tests that optimize a patient's exposure to chemotherapy, has been certified as a registered CLIA Laboratory from the Office of Clinical Standards and Quality (OCSQ), a division of The ...
Tags: Laboratory Certification, Saladax
Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
Marks & Spencer (M&S) today publishes its latest Plan A Report which shows progress against the programme’s 180 sustainability commitments, including its stretching 2015 targets. 139 of the 180 commitments have been achieved ...
Tags: Apparel, Marks&Spencer
The US Patent and Trademark Office (USPTO) has granted a patent to GenSpera for the activation of peptide prodrugs by HK2, which is an enzyme secreted by prostate cancer cells. Composition of a series of prodrugs activated by HK2 enzyme ...
Tags: Peptide Prodrugs, Medicine
The FDA has cleared Celgene's supplemental new drug application (sNDA) for Revlimid (lenalidomide) for the treatment of patients with relapsed or refractory mantle cell lymphoma (MCL). The approval follows positive data from MCL-001 phase ...
Proton therapy systems developer Mevion Medical has delivered the superconducting synchrocyclotron accelerator for its Mevion S250, which is presently under installation at the Peggy and Charles Stephenson Cancer Center at the University of ...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Celgene International's oral anti-cancer therapy Pomalidomide. The positive results from the MM-003 study of ...
Danish biotechnology company Zealand Pharma and partner, the Swiss pharma group Helsinn have jointly cHelsinn's Phase IIa study with elsiglutide for the prevention of chemotherapy-induced diarrhea in cancer patients has been completed with ...
Tags: Health, Medicine, biotechnology
Daiichi Sankyo Company has filed a supplemental new drug application for extended indication of anticancer agent Topotecin intravenous drip infusion 40mg, 100mg with the Japan's Ministry of Health, Labor and Welfare. Topotecin intravenous ...